PBA
Paradigm Biocapital Advisors’s Immunocore IMCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,787,176
| Closed | -$116M | – | 41 |
|
|
2024
Q1 | $116M | Buy |
1,787,176
+333,293
| +23% | +$21.7M | 4.09% | 7 |
|
|
2023
Q4 | $99.3M | Buy |
1,453,883
+69,197
| +5% | +$4.73M | 4.65% | 8 |
|
|
2023
Q3 | $71.9M | Buy |
1,384,686
+114,562
| +9% | +$5.95M | 4.88% | 8 |
|
|
2023
Q2 | $76.2M | Buy |
1,270,124
+143,868
| +13% | +$8.63M | 5.88% | 3 |
|
|
2023
Q1 | $55.7M | Buy |
1,126,256
+268,331
| +31% | +$13.3M | 5.28% | 6 |
|
|
2022
Q4 | $49M | Buy |
857,925
+84,846
| +11% | +$4.84M | 5.75% | 8 |
|
|
2022
Q3 | $36.3M | Buy |
773,079
+105,662
| +16% | +$4.96M | 4.84% | 7 |
|
|
2022
Q2 | $24.9M | Buy |
667,417
+168,227
| +34% | +$6.28M | 4.97% | 9 |
|
|
2022
Q1 | $14.9M | Buy |
499,190
+364,941
| +272% | +$10.9M | 3.95% | 10 |
|
|
2021
Q4 | $4.6M | Buy |
+134,249
| New | +$4.6M | 1.31% | 22 |
|